Trial Profile
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2023
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Carcinoma; Endometrial cancer; Glandular and epithelial neoplasms
- Focus Adverse reactions
- 20 Apr 2021 Status changed from active, no longer recruiting to completed.
- 13 Mar 2020 Planned End Date changed from 1 Dec 2019 to 1 Mar 2020.
- 08 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Dec 2019.